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Abstract— In this study, we investigated the discrimination 
power of short-term Heart Rate Variability (HRV) for 
discriminating normal subjects versus Chronic Heart Failure 
(CHF) patients. We analyzed 1,914.40 hours of ECG of 83 patients 
of which 54 are normal and 29 are suffering from CHF with New 
York Heart Classification (NYHA) I, II, III, extracted by public 
databases. Following guidelines, we performed time and frequency 
analysis in order to measure HRV features. To assess the 
discrimination power of HRV features we designed a classifier 
based on the Classification and Regression Tree (CART) method, 
which is a non-parametric statistical technique, strongly effective 
on non-normal medical data mining. The best subset of features 
for subject classification includes RMSSD, total power, high 
frequencies power and the ratio between low and high Frequencies 
power (LF/HF). The classifier we developed achieved specificity 
and sensitivity values of 79.31% and 100% respectively. 
Moreover, we demonstrated that it is possible to achieve specificity 
and sensitivity of 89.7% and 100% respectively, by introducing 
two non-standard features ∆AVNN and ∆LF/HF, which account 
respectively for variation over the 24 hours of the average of 
consecutive normal intervals (AVNN) and LF/HF. Our results are 
comparable with other similar studies, but the method we used is 
particularly valuable because it allows a fully 
human-understandable description of classification procedures, in 
terms of intelligible “if … then …” rules. 
 
Index Terms— HRV, CHF, CART, NYHA classification  
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I. INTRODUCTION 
EART rate variability is a non-invasive measure 
commonly used to assess the influence of autonomic 
nervous system (ANS) on the heart [1]. HRV is widely studied 
in patients suffering from Chronic Heart Failure (CHF) [2-16]. 
CHF is a patho-physiological condition in which an abnormal 
cardiac function is responsible for the failure of the heart to 
pump blood as required by the body. CHF is chronic, 
degenerative and age related [17] [18]. Therefore, the growing 
number of elderly people in western countries could be one of 
the reasons that the number of patients with CHF is increasing 
[19]. Moreover, heart failure (HF) is asymptomatic in its first 
stages. Therefore, early detection is crucial to avoid the 
condition worsening and to prevent complication of clinical 
conditions, which may cause higher social costs. Therefore, new 
non-invasive and low-cost techniques for early assessment of 
HF severity, could contribute to containing the number of 
patients and related costs. 
One of the most diffused measurements of the severity of 
CHF is the New York Heart Association (NYHA) classification, 
which is a symptomatic functional scale [20]. Nonetheless, this 
scale is criticized because, being based on subjective 
evaluation, it is amenable to inter-observer variability [21]. For 
an objective assessment of HF, international guidelines [22] 
suggest that the most effective diagnostic test is the 
comprehensive 2-dimensional echocardiogram coupled with 
Doppler flow studies to determine whether abnormalities of 
myocardium, heart valves, or pericardium are present and in 
which chamber. As far as electrocardiography is concerned, the 
same guidelines evidenced that conventional 12-lead 
electrocardiogram (ECG) should not form the primary basis for 
determining the specific cardiac abnormality responsible for the 
development of CHF, because of low sensitivity and specificity. 
Therefore, an interesting question is whether HRV analysis 
may improve both sensitivity and specificity of ECG 
examination, thus providing a robust independent tool for HF 
assessment. 
The majority of literature studies used HRV measures for the 
prognosis of the disease, in particular as predictor of the risk of 
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mortality [5, 7, 10, 12-15]. A small number of studies focused 
on using HRV measures for CHF diagnosis. Asyali [23] studied 
the discrimination power of long-term HRV measures 
(time-domain and FFT-based frequency domain) and, using 
linear discriminant analysis and a Bayesian Classifier, obtained 
sensitivity and specificity rate of 81,82% and 98,08% 
respectively. Isler et al. [24] investigated the discrimination 
power of short-term HRV measures, including wavelet entropy. 
In their studies, they achieved the best performance using 
Genetic Algorithms and k-Nearest Neighbor Classifier, 
resulting in a sensitivity rate of 100.00% and specificity rate of 
94.74%. Although these studies reached interesting results, they 
all use difficult methods, which could be too complex for the 
daily activity of clinicians. 
The aim of this study is to investigate the power of short-term 
HRV features in classifying CHF patients according to disease 
severity, by using Classification and Regression Tree (CART). 
We identify the subset of features achieving the highest 
sensitivity and specificity rate in distinguishing CHF patients 
from normal subject. Moreover, we evaluated the improvement 
in the classifier performance by introducing two non-standard 
HRV features, ∆AVNN and ∆LF/HF, which account 
respectively for variation over the 24 hours of the average of 
consecutive normal intervals (AVNN) and LF/HF.  
CART was applied to HRV measures for other 
investigations, such as the diagnosis of Obstructive Sleep Apnea 
Syndrome [25], or the analysis of the relationship between HRV 
and menstrual cycle in healthy young women [26]. As far as the 
authors’ knowledge, CART has not been applied yet to HRV 
analysis for CHF diagnosis. 
CART [27] is a method widely used in several applications of 
pattern recognition for medical diagnosis [28]. This method is 
particularly interesting because its results are fully 
understandable without advanced mathematical skills: the 
models behind this method can easily be expressed as logic 
rules. Other powerful methods are not easily 
human-understandable [29], whilst in medical applications the 
intelligibility of the method is strongly appreciated especially 
for clinical interpretation of results [29]. Moreover, CART 
requires no assumptions regarding the underlying distribution of 
features’ values [30]. 
The CART algorithm iteratively splits the data set, according 
to a criterion that maximizes the separation of the data, 
producing a tree-like decision structure. More details of the 
CART model building process can be found in Breiman et al. 
[27]. We used the “leave one out” cross-validation technique 
[31]. 
In order to maximize the reproducibility of our investigation, 
we applied this method on public databases [32], and we 
analyzed only standard measures [1].  
II. METHOD 
A. Data 
We performed a retrospective analysis using two RR interval 
databases, one with normal middle-aged subjects, the other with 
patients suffering from CHF in NYHA I-III. The data of normal 
subjects was retrieved from the Normal Sinus Rhythm RR 
Interval Database [32]. It includes RR intervals extracted from 
24-hour ECG-Holter of 30 men and 24 women, aged 29-76 
years (61±11). The data for the CHF group was retrieved from 
the Congestive Heart Failure RR Interval Database [32]. It 
includes RR intervals extracted from 24-hour ECG-Holter 
recordings of 8 men, 2 women, and 19 unknown-gender 
subjects, aged 34-79 years (55±11): 4 subjects were classified 
as NYHA class I, 8 NYHA class II and 17 NYHA class III. The 
RR interval records are provided with beat annotations obtained 
by automated analysis with manual review and correction. The 
original ECG records were digitalized at 128 samples per 
second. 
B. Short-term HRV feature measurements 
We chose to perform standard short-term HRV analysis, 
according to International Guidelines [1]. Therefore, we 
extracted 5-min RR Interval Time Series (RRITS) excerpts 
from the 24-hour records and processed them using PhysioNet's 
HRV Toolkit [32]. We chose this tool, since it is rigorously 
validated and open-source. This toolkit provides calculation of 
basic time- and frequency-domain HRV features widely used in 
the literature [1] and reported in Table 1.  
Furthermore, this toolkit estimates frequency-domain HRV 
features by Lomb-Scamble periodogram (LS) [33] which can 
produce a more accurate estimation of the PSD than FFT-based 
methods for RR data [34], without pre-processing. Moreover, it 
calculates NN-RR ratio, which represents the fraction of total 
RR intervals that are classified as normal-to-normal (NN) 
intervals. This ratio is used as a measure of data reliability and if 
it is less than 80% the excerpt is excluded.  
Finally, to reduce false negatives, we introduced two 
non-standard measurements: the difference, over the 24 hours, 
between the maximum and the minimum values both for AVNN 
and LF/HF, called respectively ∆AVNN and ∆LF/HF. These two 
measurements account for AVNN and LF/HF variation in the 
same subject over the 24 hours and are computed by a MS Excel 
worksheet. 
TABLE I 
SELECTED HRV FEATURES 
Measure Description Unit 
AVNN Average of all NN intervals ms 
SDNN Standard deviation of all NN intervals. ms 
RMSSD 
 
The square root of the mean of the sum of the squares of 
differences between adjacent NN intervals 
ms 
pNN50 Percentage of differences between adjacent NN intervals 
that are > 50 ms 
% 
   
TOTPWR Total spectral power of all NN intervals 0-0.4 Hz. ms2 
VLF Total spectral power of all NN intervals 0-0.04 Hz ms2 
LF Total spectral power of all NN intervals 0.04-0.15 Hz ms2 
HF Total spectral power of all NN intervals 0.15-0.4 Hz ms2 
LF/HF Ratio of low to high frequency power  
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C. Classification 
In order to find the best subset of features, we adopted the 
so-called exhaustive search method, investigating the predictive 
value of all the possible combinations, without repetitions, of K 
out-of-N features [35]. Then we chose as best combination the 
one that maximizes specificity and sensitivity. Since the number 
of features is N=9, we used 29=512 subsets of features to train 
and test the same number of classification trees. The 
classification process is subdivided into two steps: excerpts 
classification and subject classification. With the first, each 
excerpt from a subject is classified as normal or abnormal. With 
the latter, the subject is classified as normal or CHF, according 
to the percentage of excerpts classified as CHF. Finally, we tried 
to enhance the second step by introducing the two non-standard 
HRV measurements defined above (section 2.2). Figure 1 
shows the whole process of classification.  
1) Excerpts classification 
The excerpts of each subject were labeled with a binary 
index, according to the status of the subject (0=normal; 
1=NYHA I-II-III). Excerpts extracted from the same subject 
cannot be assumed to be uncorrelated: therefore, if some 
excerpts from one subject are used to train a tree, then none of 
his excerpts can be used to test the same tree, otherwise the 
specificity and sensitivity of the tree would be higher. 
Therefore, we divided the training- and testing-set according to 
subjects and not to their excerpts. 
Afterwards, for each combination of features, leaving out one 
of the subjects, we used the excerpts of the others to train a 
CART, using as splitting criterion the Gini index [27]. It is a 
measure of the impurity of each node t, which, for binary 
classification, can be computed as follows: 
 
 (1) 
 
where “t” is the considered node, “i” is the class label, p(i|t) is 
the conditional probability that a subject fallen in the node “t” 
belongs to the class “i”. 
We repeated this step for each subject left out and for each 
combination of features. Then we tested each tree with the 
excerpts of the subject left out during its training. Via binary 
classification of excerpts, we associated to each subject a vector 
(V) containing a 1 for each excerpt classified as abnormal and 0 
for each excerpt classified as normal. 
2) Subject classification 
From the vector V, we computed the number of excerpts 
classified as normal (N0) and the number of excerpts classified 
as abnormal (NA). We tried two different models for the Tree B 
(Fig.1): “Tree B1” and “Tree B2”. The former classifies 
subjects on the base of the ratio R=N0/(N0+NA): if R is greater 
than a threshold (α), the subject is considered normal. The latter 
uses the ratio R and the two non-standard variables introduced 
above (section 2.2): ∆AVNN and ∆LF/HF. In both cases, to 
choose the optimal threshold α, we considered all its possible 
values between 0 and 1, with a step of 0.01. Then, studying the 
ROC curve [36], we choose the value of α maximizing the 
sensitivity and specificity of the classifier (Figure 3). 
3) Validation 
As discussed above excerpts extracted from the same subject 
cannot be assumed to be uncorrelated, therefore we divided the 
data into training-set and test-set for subjects and not for 
excerpts, although this reduces the datasets. Therefore, we used 
the leave-one-out cross-validation method [31]. In this method, 
the classifier is trained using the whole dataset except the data of 
one subject and then tested on the excerpts of the excluded 
subject. This process is repeated for all the subjects in the 
dataset. 
D. Performance measurements 
To measure the performance of each classifier, we used the 
confusion matrixes [37] From these matrices, we computed the 
widely used measures reported in table II for binary 
classification in order to enable the comparison of our method 
with others. 
We selected the subset of features which obtained the best 
sensitivity. The final model was obtained by pruning the trees at 
the first six levels in order to improve the intelligibleness. 
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Figure 1: Workflow of Classification  
TABLE II 
BINARY CLASSIFICATION PERFORMANCE MEASURES 
Measure (Abbreviation) Formula 
Accuracy (Acc) 
FNFPTNTP
TNTP
+++
+
 
Precision (Pre) 
FPTP
TP
+
 
Sensitivity (Sen) 
FNTP
TP
+
 
Specificity (Spe) 
TNFP
TN
+
 
Area Under the Curve (AUC) ;2
1
 





+
+
+
=
FPTN
TN
FNTP
TPAUC
 
 TP: the number of CHF patients detected. TN: number of normal subject detected. 
 FP: number of normal subject incorrectly labeled as CHF. FN: number of CHF 
patients incorrectly labeled as normal. 
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TABLE VII 
CLASSIFICATION PERFORMANCE MEASUREMENTS 
 TP FP TN FN ACC PRE SEN SPE AUC 
Tree B1 23 0 54 6 92.8 100.0 79.3 100.0 89.7 
Tree B2 26 0 54 3 96.4 100.0 89.7 100.0 94.8 
Tree B1: obtained using: RMSSD, TOTPWR, HF, LF/HF 
Tree B2: Tree B1 + features ∆AVNN and ∆LF/HF 
 
Results obtained with this tree are presented and discussed here. 
III. RESULTS  
The subset of features achieving the best results in classifying 
the excerpts is constituted by: RMSSD, TOTPWR, HF and 
LF/HF. Figure 2 shows the final model of the Tree A, for 
excerpts classification with the best subset of features. At each 
node, if condition expressed in the node is true then, the excerpt 
goes in the left sub-node (or leaf). For instance, if TOTPWR is 
less than 212.168 ms2, the excerpt is labeled as 1 (CHF), if not, 
the LF/HF ratio is considered, and so on. All the terminal nodes 
for CHF class are on the left of their parent nodes. This reflects 
the fact that CHF subjects have a depressed HRV. 
Figure 3 shows the ROC curve for all the possible value of α, 
for both trees. The best thresholds α was assessed to 0.68±1 and 
to 0.65±4, respectively with the Tree B-1 or B2. 
Table III, shows the confusion matrix of the classifier with 
the tree B1, while Table IV reports the confusion matrix per 
NYHA classes for the same tree. 
It is possible to significantly reduce the false negatives, 
improving the sensitivity of the classifier, enhancing the subject 
classifier with the tree B1, which bases on the two non-standard 
measures, ∆AVNN and ∆LF/HF, introduced at the end of section 2.2. 
Figure 4 shows the final model of the tree B2. 
The confusion matrixes of the classifier enhanced with the 
tree B2 are reported in Tables V and VI. 
The performances of the classifier with the trees B1 and B2 
are reported in the table VII. 
Node 1
TOTPWR<451
Node 2
TOTPWR<212
Node 3
LF/HF<1.35
Node 4
RMSSD <12.4
Node 5
LF/HF<2.44
Node 6
RMSSD <16.3
Node 7
RMSSD <28.9
Node 8
LF/HF<1.42
Node 9
HF < 115
Leaf 1
Class = 1
Leaf 2
Class = 1
Leaf 6
Class = 1
Leaf 3
Class = 1
Leaf 4
Class = 0
Leaf 7
Class = 0
Leaf 8
Class = 0
Leaf 9
Class = 1
Leaf 10
Class = 0
Leaf 5
Class = 0
 
Figure 2: excerpt classification decision tree. The 5-mins RR intervals labeled 
as class 1, are considered abnormal, class 0 normal 
 
Figure 3: ROC curve, representing how sensitivity and specificity vary for α 
changing from 0 to 1 
Node 2
∆AVNN<300
Node 3
∆LF/HF<6 
Leaf 4
NORMAL
Leaf 1
CHF
Node 1
RATIO<.6
Leaf 2
CHF
Leaf 3
CHF
 
Figure 4 Tree B2: subjects classification according to 
non-standard features ∆AVNN and ∆LF/HF 
 
TABLE III 
CONFUSION MATRIX USING THE TREE B1 
 
Classified  
Normal 
Classified  
CHF 
Normal 54 0 
CHF 6 23 
 
TABLE V 
CONFUSION MATRIX USING THE TREE B2 
 
Classified 
Normal 
Classified  
CHF 
Normal 54 0 
CHF 3 26 
 
TABLE VI 
CONFUSION MATRIX PER NYHA USING THE TREE B2 
 
Classified  
Normal 
Classified 
CHF 
Normal 54 0 
NYHA I 1 3 
NYHA II 1 7 
NYHA III 1 16 
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The results indicate that 4 standard short-term features are 
sufficient to distinguish between normal subjects and CHF 
patients achieving a specificity and sensitivity of 79.31% and 
100% respectively. Moreover, by introducing two more 
non-standard features it is possible to achieve specificity and 
sensitivity of 89.7% and 100% respectively. 
IV. DISCUSSION 
In this study, we investigated the class discrimination power 
of 9 standard short-term HRV measures using classification and 
regression tree (CART). Moreover, we demonstrated that it is 
possible to enhance the discriminative power of these measures 
by adding a few non-standard measures of HRV. The results 
show that it is possible to discriminate normal subjects from 
CHF ones by using short-term HRV measures, extracted from 
h24 Holter registrations.  
As regards the discriminative power of the features, the best 
subset of features includes three frequency domain measures, 
confirming the importance of power spectral density analysis in 
investigating short-term excerpts [1]. RMSDD is the only 
time-domain measure selected, this may be because pNN50 and 
SDNN are strongly correlated with RMSDD and TOTPWR, 
respectively [1]. It is worth to notice that SDNN does not appear 
in the best  subset of features, even if it has been recognized as 
having the highest class discrimination power [23], among long 
term HRV features, and as a strong univariate predictor of 
mortality [38]. In fact, Asyali [23] showed that a depressed 
SDNN (<91.82 ms) is significant to identify CHF, while 
Bilchick [38] reported that a depressed SDNN (<70 ms and 
<30ms, respectively for long-term and 5-min records) is 
significantly associated with increased mortality. However, the 
predominant position of TOTPWR in nodes 1 and 2 (see Figure 
2) confirms indirectly the importance of SDNN for two reasons: 
TOTPWR and SDNN are strongly correlated [1, 16, 38]; in our 
dataset all the subjects with TOTPOW<451ms2 presented an 
SDNN<30ms, consistently with Bilchick’s conclusions [38]. 
Nonetheless, when using CART, TOTPWR seems to be more 
effective than SDNN in detecting CHF patients. 
The set of rules, reported in figure 2, is clinically consistent, 
even if the classifier did not use any a priori clinical knowledge. 
In fact, the main clinical results of this study is that the leafs 
containing abnormal excerpts are on “left”, which reflects a 
depressed value of all the involved features. This is consistent 
with our previous research [16] and with the results showed by 
Bigger [3], Musialik-Lydka [11] and Arbolishvili [13], who 
stated that standard HRV measures were significantly lower in 
CHF patients than in normal subjects. However, Arbolishvili 
[13] showed that high frequency power (HF) was not lowered 
and this exception is apparently in contrast with our results (see 
node 9 figure 2). This inconsistency may be explained by 
considering that HF may have a discriminative power only for 
the subgroups of excerpts which had relative high value of 
TOTPWR (TOTPWR> 451) and intermediate values of LF/HF 
and RMSDD (1.42<LF/HF<2.44; 16.3<RMSSD <28.9).  
It should be underlined that comparisons with the results of 
other authors have some limitations: heterogeneity between 
lengths of analyzed recordings (5 minutes versus 24 hours) and 
differences in the methods for estimating power spectral 
density. The performance of the proposed classification could 
be compared with a few previously published studies, which 
used the same databases, as reported in Table VIII. 
Compared to the other studies, we obtained higher precision 
and specificity values, but lower sensitivity. The performance 
measures of our classifiers are higher than or comparable with 
those of Asyali’s classifier, which considered HRV long term 
measures. Moreover, we considered all the subjects, even those 
rejected by Asyali because of their low quality (24-hour NN/RR 
less than 90%). The performance measures of our classifier are 
lower than those of Isler’s classifier, which considered HRV 
short-term measures, including wavelet entropy measures. 
Perhaps this is because of the discrimination power of wavelet 
entropy measures, which have not been considered in this study 
because they are complex non-standard short-term measures, 
presumably complex for most clinicians. In this regard, in 
comparison with other studies, we provided a set of rules, which 
are fully understandable by cardiologists.  
As regards classification results and the NYHA classes, as 
shown in Table IV, the tree B1 achieves low performance, 
especially on the NYHA I patients. This result could be justified 
because these patients could have an HRV not so different from 
normal subjects. Nonetheless, this result could be due to the 
small number of patients in this class in the dataset. In both 
cases the tree B2, although in small numbers, enhances the 
classifier also for NYHA I patients. In this regard, Table VI 
shows that it is possible to further improve the performance of 
the classifier by adding few new variables, ∆AVNN and ∆LF/HF, 
which take into account features variation over the 24h in the 
same subject. 
Finally, a limitation of our study could be the small dataset. 
For instance, the value chosen for the threshold α could depend 
by the dataset we used, which was unbalanced. In fact, the ratio 
of the number of normal subjects on the total number of subjects 
in the dataset is 0.65 (54 normal subjects and 29 CHF patients) 
V. CONCLUSION 
In this study, we showed that standard short-term HRV 
measures such as RMSSD, TOTPWR, HF and LF/HF allow 
discriminating normal subjects from CHF patients, with a 
specificity and sensitivity of 79.3% and 100% respectively. 
Specificity is higher for the patients with NYHA II and III, 
rising up to the 87.5% and the 82.3% respectively. This result 
can be enhanced, using two additional non-standard measures 
TABLE IV 
CONFUSION MATRIX PER NYHA USING THE TREE B1 
 
Classified 
Normal 
Classified  
CHF 
Normal 54 0 
NYHA I 2 2 
NYHA II 1 7 
NYHA III 3 14 
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over the 24h, ∆AVNN and ∆LF/HF, which account respectively 
for variation over the 24 hours of AVNN and LF/HF, reflecting 
the variation of HRV in the day. In this case, with the same 
sensitivity, the specificity increases to 89.7%. 
Moreover, as shown in figure 2, all the terminal nodes for 
CHF class are on the left of their parent nodes, reflecting the fact 
that CHF subjects have a depressed HRV. 
Performance results are better if compared to other studies 
using standard measures, although in 24 hours, and are 
comparable with previous studies using complex measures as 
wavelet entropy ones. In both cases, it should be pointed out that 
we did not use complex methods, providing a fully 
understandable set of rules easily expressed as ‘if … then’, 
which can be fully understood by a greater number of clinicians. 
Finally, the proposed method meets all our requirements 
because it is: fully understandable; non-invasive and low-cost; 
provides an objective classification; improves sensitivity and 
specificity of ECG examinations for diagnosis of CHF. 
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